Form 4: Edwards Lifesciences Executive Larry L. Wood Reports Stock Sale
SEC Form 4 Filing
Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences, reports the sale of 25,000 shares of common stock and adjustments to beneficial ownership.
Summary
- On November 5, 2024, Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences Corp, sold 25,000 shares of common stock at a weighted average price of $65.9145.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 1, 2024.
- Following the transaction, Wood directly owns 198,525.739 shares of Edwards Lifesciences common stock.
- Wood also indirectly owns 148.1703 shares through a 401(k) plan.
- A transfer of 347.7139 shares to Wood's former spouse in July 2022, pursuant to a qualified domestic relations order, is also noted.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-existing trading plan. There is no indication of positive or negative implications for the company.
Industry Context
This filing is a routine disclosure of insider trading activity. It provides transparency to the market regarding the transactions of company executives.
Key Dates
| Date | Description |
|---|---|
| July 2022 | Transfer of 347.7139 shares of common stock to the reporting person's former spouse pursuant to a qualified domestic relations order. |
| 05/01/2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 11/05/2024 | Date of the stock sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.